Chart, Financials, Historical Prices, Industry, Messages, Profile, Reports, Research, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 39)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
24-Nov-09New Constructs, LLCN/ADEPO: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10  View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299  View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199  View Abstract
22-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: DEPOMED INC5$25  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: DEPOMED -- DEPO1$4  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ALXA , ALTH , ARIA , COR , DEPO , ISTA , PTIE , QCOR -- DRUGS3$4  View Abstract
17-Nov-09EconomicInvestorN/A"The Economy Matters" Report for DEPO: the economy's impact on DEPO's price and risk, featuring the powerful EconomicInvestor Star Rating6$15  View Abstract
16-Nov-09Roth Capital Partners, Inc.Research DepartmentMorning Call Summary18$50  View Abstract
15-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: DEPOMED INC5$25  View Abstract
14-Nov-09Wright ReportsN/AWright Investors Service Comprehensive Report for DepoMed, Inc.42$65  View Abstract
Next 20

Brokerage Reports (Showing 1 to 10 of 12)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
16-Nov-09Roth Capital Partners, Inc.Research DepartmentMorning Call Summary18$50  View Abstract
13-Nov-09Roth Capital Partners, Inc.Scott R. Henry CFA, Andrew VainoMeetings with management: Putting the ship back on course9$254 Stars  View Abstract
5-Nov-09Roth Capital Partners, Inc.Research DepartmentMorning Call Summary25$75  View Abstract
5-Nov-09Roth Capital Partners, Inc.Scott R. Henry CFA, Andrew VainoQ3 fundamentals strong, but focus on patents and OTC decision7$254 Stars  View Abstract
30-Oct-09Caris & CompanyDavid MoskowitzDEPO - 3Q As Expected9$25  View Abstract
30-Oct-09Roth Capital Partners, Inc.Research DepartmentMorning Call Summary20$50  View Abstract
30-Oct-09Thomson StreetEventsN/ADEPO - Event Transcript of Depomed conference call, Oct. 29, 2009 / 5:00pm ET18$75  View Abstract
30-Oct-09Roth Capital Partners, Inc.Scott R. Henry CFA, Andrew VainoHistory Shows Now To Be A Good Entry Point10$254 Stars  View Abstract
21-Oct-09Caris & CompanyJames MolloyDEPO-Que Serada, Serada – Initiating with 1*/Buy20$50  View Abstract
13-Oct-09Roth Capital Partners, Inc.Research DepartmentMorning Call Summary9$25  View Abstract
Next 2

Independent Reports (Showing 1 to 10 of 27)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
24-Nov-09New Constructs, LLCN/ADEPO: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199View Abstract
22-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: DEPOMED INC5$25View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: DEPOMED -- DEPO1$4View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ALXA , ALTH , ARIA , COR , DEPO , ISTA , PTIE , QCOR -- DRUGS3$4View Abstract
17-Nov-09EconomicInvestorN/A"The Economy Matters" Report for DEPO: the economy's impact on DEPO's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
15-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: DEPOMED INC5$25View Abstract
14-Nov-09Wright ReportsN/AWright Investors Service Comprehensive Report for DepoMed, Inc.42$65View Abstract
8-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: DEPOMED INC5$25View Abstract
Next 17

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.